Diagnosis and Management of Fetal Growth Restriction Online Course

This course is based on SMFM Consult Series #52: Diagnosis and Management of Fetal Growth Restriction, published in 2020 in the American Journal of Obstetrics and Gynecology and presents SMFM’s recommendations about the diagnosis, surveillance, and management of FGR. 

After completing the course, the learner should be able to:

1. Explain why the terms fetal growth restriction (FGR) and small for gestational age (SGA) should not be used interchangeably.
2. Describe the variations in diagnostic criteria for FGR and summarize the evidence that supports SMFM’s diagnostic criteria.
3. List components of the initial workup after the diagnosis of early and late FGR.
4. Discuss the FGR surveillance methods recommended by SMFM and the rationale for their recommendation.
5. Describe the management and delivery options in the setting of FGR based on the results of umbilical artery Doppler velocimetry results.

This course is designated for a maximum of 7 AMA PRA Category 1 Credits™. Participants must complete the pretest, online course, and completion survey to obtain credits.

This course expires on July 17, 2025. 

Continuing Medical Education Credits

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Global Learning Collaborative and the Society for Maternal-Fetal Medicine. The Global Learning Collaborative is accredited by the ACCME to provide continuing medical education for physicians.

Global Learning Collaborative designates this enduring activity for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The AMA PRA Category 1^TM credits from this activity are accepted by the AIUM for practice accreditation in Standard OB and Detailed First and Detailed Second/Third Trimester Ultrasound.

Disclosures

In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an accredited educational activity disclose all financial relationships with any ineligible company within the preceding 24 months. 

The following individuals in control of this course’s content have no relevant financial relationships:

Course Directors:

Christina A. Herrera, MD, Orlando Health, Orlando, FL

Anthony Shanks, MD, Indiana University, Indianapolis, IN

Authors:

Lauren Carlos, MD, Central Dupage Hospital, St. Charles, IL

Juliana Martins, MD, Eastern Virginia Medical School, Norfolk, VA

Andrea Shields, MD, MSCR, University of Connecticut, Avon, CT

Reviewers:

Alison Cahill, MD, MSCI, University of Texas, Austin, TX

Christina Han, MD, Geffen School of Medicine, Los Angeles, CA

Lori Harper, MD, MSCI, Dell Medical School, University of Texas, Austin, TX

Heidi Leftwich, DO, University of Massachusetts, Worcester, MA

Christian Pettker, MD, Yale University, New Haven, CT

Flint Porter, MD, University of Utah Health, Salt Lake City, UT

Kavitha Ram, MD, Metropolitan Hospital Center, New York, NY

Anthony Sciscione, MD, Christiana Care, Wilmington, DE

Staff:

Kathleen Scogna, Senior Director of Education, Society for Maternal-Fetal Medicine, Washington, DC 

The following individuals in control of this course’s content have the following relevant financial relationships:

Authors:

Alfred Abuhamad, MD, Eastern Virginia Medical School, Norfolk, VA: SonoSim, Trice, Diagnoly, Pulsenmore--consulting fees

Joseph Biggio, MD, MS, Ochsner Health, New Orleans, LA: Mirivie--research grant

Nathan Blue, MD, University of Utah Health, Salt Lake City, UT: Samsung Medison and Moderna—research grants

Andrea Edlow, MD, MSc, Massachusetts General Hospital, Boston, MA: Merck Pharmaceuticals—research grant; Mirvie, Inc.—consulting fees

Mishella Perez, RDMS, RDCS, FAIUM, Scripps Health, San Diego, CA: GE Healthcare—consulting fees

Reviewers:

Richard Burwick, MD, MPH, San Gabriel Valley Perinatal Medical Group, West Covina, CA: Alexion, AstraZeneca Rare Disease--research grants; Comanche BioPharma, UCB Bioscience--consulting fees

Lorraine Dugoff, MD, University of Pennsylvania, Philadelphia, PA: Labcorp, Natera—research grants 

Cynthia Gyamfi-Bannerman, MD, MS, University of California, San Diego, CA: Hologic--consulting fees

Torri Metz, MD, University of Utah Health, Salt Lake City, UT: Pfizer—research grant

Mary Norton, MD, University of California, San Francisco, CA: Luna Genetics—consulting fees

Luis Pacheco, MD, University of Texas Medical Branch, Galveston, TX: Coagulant Therapeutics—consulting fees

Sindhu Srinivas, MD, MSCE, University of Pennsylvania, Philadelphia, PA: Huff Powell & Bailey LLC, Palladium Risk Retention Group—consulting fees 

For this activity, all relevant financial relationships have been mitigated.